Danaher Corporation $DHR Stock Sold by Private Wealth Partners LLC

Private Wealth Partners LLC reduced its holdings in shares of Danaher Corporation (NYSE:DHR) by 5.0% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 83,559 shares of the conglomerate’s stock after selling 4,416 shares during the quarter. Danaher comprises approximately 1.3% of Private Wealth Partners LLC’s holdings, making the stock its 22nd biggest position. Private Wealth Partners LLC’s holdings in Danaher were worth $18,513,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Marquette Asset Management LLC lifted its holdings in Danaher by 192.1% during the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 73 shares during the last quarter. N.E.W. Advisory Services LLC acquired a new position in shares of Danaher in the second quarter valued at $25,000. Main Street Group LTD acquired a new position in shares of Danaher in the first quarter valued at $25,000. Field & Main Bank bought a new position in shares of Danaher in the second quarter valued at about $29,000. Finally, Evolution Wealth Management Inc. raised its position in shares of Danaher by 208.0% in the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 104 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR traded up $0.61 during midday trading on Friday, reaching $230.36. 3,935,897 shares of the stock were exchanged, compared to its average volume of 4,912,513. The stock’s 50 day simple moving average is $216.32 and its 200 day simple moving average is $197.35. The company has a market cap of $161.94 billion, a P/E ratio of 37.70, a PEG ratio of 2.87 and a beta of 0.76. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.63 and a debt-to-equity ratio of 0.45.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. During the same period in the prior year, the company posted $1.89 earnings per share. Danaher’s revenue was up 8.3% compared to the same quarter last year. On average, sell-side analysts expect that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s dividend payout ratio is presently 26.19%.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher reported third-quarter adjusted earnings of $2.11 per share, above the $1.92 analyst consensus, while revenue reached approximately $6.55 billion. Revenue increased 8.3% year over year, and management raised its full-year 2026 adjusted EPS outlook. Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View
• Positive Sentiment: Analysts raised their valuation targets following the results. TD Cowen and JPMorgan lifted targets to $270, Goldman Sachs raised its target to $275, Stifel increased its target to $260, and Robert W. Baird raised its target to $254. The firms maintained bullish ratings, including Buy, Overweight and Outperform. Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
• Positive Sentiment: Management highlighted margin strength, improved execution and an increased focus on innovation and artificial intelligence, factors analysts viewed as supporting a better longer-term outlook. Danaher Earnings Call Highlights Margin Strength, AI Push
• Neutral Sentiment: Despite the earnings beat and higher targets, shares declined in the immediate post-results reaction, suggesting investors may have already priced in much of the improvement. A recent valuation comparison also frames DHR as a stock for investors weighing quality and growth against its relatively elevated valuation. Danaher Q3 Recap: Decent Results, Still A Hold
• Negative Sentiment: Danaher’s new CEO emphasized the need for better execution and innovation. TD Cowen cited tariff pressure and a cautious 2027 outlook, creating uncertainty beyond the raised 2026 guidance and helping explain why the stock did not fully respond to the strong quarterly report. Danaher Posts First Earnings Under New CEO

Analyst Ratings Changes

Several analysts recently commented on the stock. Royal Bank Of Canada lifted their target price on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday, October 5th. Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. TD Cowen boosted their price objective on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Guggenheim upped their target price on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $242.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.